phosphodiesterase 4 (pde4) inhibitor for the treatment of diabetic nephropathy

摘要

The present invention relates to the treatment of diabetic nephropathy with a) a phosphodiesterase 4 inhibitor, b) a combination of a phosphodiesterase 4 inhibitor and an angiotensin ii receptor antagonist up to 1 or c) a combination of a phosphodiesterase 4 inhibitor with an enzyme inhibitor that converts angiotensin.